EU Benefit-Risk Guidelines Put Phthalates Safety Back In The Spotlight
The European Commission is seeking comments on preliminary guidelines on how to justify the use of certain phthalates in medical devices.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-nine new guidance documents have been posted on the tracker since its last update.
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.